update
-
Spine
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard…
Read More » -
Biologics
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
Massimo Calafiore begins as President and Chief Executive Officer, effective immediately Julie Andrews is appointed as Chief Financial Officer, assuming…
Read More » -
Financial
Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility
ENGLEWOOD, Colo., November 7, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Regulatory
Bioretec postpones Annual General Meeting to a later date
TAMPERE, Finland, March 17, 2023 /PRNewswire/ — Bioretec Ltd’s Board of Directors has today decided to reschedule the date of the company’s…
Read More » -
Financial
Tenet beating expectations; announces leadership changes
In addition to exceeding its financial forecast, a national search will seek to replace its longtime CEO, who is retiring…
Read More » -
Regulatory
Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs™ trauma screw
TAMPERE, Finland, Nov. 4, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in biodegradable orthopedic implants, expects the European marketing authorization for the RemeOs™…
Read More » -
Biologics
Bone Biologics CEO Issues Letter to Stockholders
BURLINGTON, Mass., October 25, 2022 (BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today…
Read More » -
Extremities
Bioretec updates estimate of U.S. registration of RemeOs™ screws and expects approval in April 2023
TAMPERE, Finland, Oct. 14, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, continues to discuss the company’s RemeOs™ trauma…
Read More » -
Financial
Spineway-Significant increase of the turnover as of September 2022 compared with last year third quarter
Ecully, October 14, 2022 Nine-month turnover of €5.4 million, up 82% Sales double in Q3Strengthened sales in France and Europe following the development of the…
Read More » -
Shareholder Letter from Founder, Executive Chairman & CEO CJ Wiggins regarding HippoFi®
September 7, 2022 – OrthoSpineNews- Dear Shareholders, I am writing to you, to share our team’s accomplishments over the last…
Read More » -
Spine
Spineway-new development dynamics and confirmation of strategy
Ecully , June 24 , 2022 New momentum for a strong comeback on the French market Successful participation in the SFCR CongressConfirmation of the development…
Read More » -
Financial
Bioventus Amends CartiHeal Acquisition Structure
DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
SANUWAVE Business Update
Estimated May Revenue Increase of 96% Year Over Year Sales Funnel Increases 5% and System Trials Increases 2% Month Over…
Read More » -
Financial
SANUWAVE® Business Update
Sales Funnel and System Trials Increase 13% Month Over MonthLaunches Entry into Two New Vertical Markets; Initial Orders Exceed $1…
Read More » -
Financial
SANUWAVE Health to Host Conference Call and Provide Business Update
SUWANEE, GA, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care…
Read More »